Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    22357109 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Abciximab i.v. Versus i.c. in ST-elevation Myocardial Infarction
Condition: ST-elevation Myocardial Infarction
Interventions: Drug: abciximab intracoronary;   Drug: abciximab intravenously

Indicates status has not been verified in more than two years